company

ONCOLOMED AS

4018 STAVANGER

Return on Equity
−106,91 %
Current Ratio
0,34
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue850 000
Net Income294 000
Total Assets139 000
Total Equity−275 000
Income (NOK)2022
Revenue850 000
Expenditure554 000
Operating Profit296 000
Financial Income1 000
Financial Costs3 000
Financial Balance−2 000
Earnings Before Tax294 000
Tax0
Net Income294 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets139 000
Total Assets139 000
Total Retained Equity−335 000
Total Equity−275 000
Total Long-Term Debt0
Total Current Debt414 000
Total Equity and Debt139 000
Cash flow (NOK)2022
Sales Income0
Other Income850 000
Revenue850 000
Cost of Goods Sold13 000
Salary Costs208 000
Depreciation0
Impairment0
Expenditure554 000
Operating Profit296 000
Financial Income1 000
Financial Costs3 000
Financial Balance−2 000
Dividends0
Net Income294 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank37 000
Total Current Assets139 000
Total Assets139 000
Total Equity−275 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors165 000
Unpaid Taxes34 000
Dividends0
Other Current Debt215 000
Total Current Debt414 000
Total Equity and Debt139 000
Financial indicators2022
Return on Equity−106,91 %
Debt-to-Equity Ratio−0
Operating Profit Margin34,82 %
Current Ratio0,34
Quick Ratio0,34
Equity Ratio−1,98
Gross Profit Margin98,47 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English